Trial intelligence / Profile preview

Modafinil and caffeine for vigilance during the circadian trough in healthy RNLAF aircrew

NL-OMON22963Unknown

Sponsor
n.a.
Start
Apr 2018
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of modafinil and caffeine (3 arms), sponsored by n.a. Primary endpoints: Vigilance & Tracking Test (VigTrack) root mean square of tracking error, Vigilance & Tracking Test (VigTrack) percentage omissions and 6 more. Status: unknown.

02

Drugs

modafinilcaffeine

Beyond the preview

Go deeper on NL-OMON22963.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON22963.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call